Cystic Fibrosis Therapeutics Market Size, Share, Demand, Trends and Forecast 2023-2028

IMARC Group has recently released a new research study titled "Cystic Fibrosis Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2028", offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.

How big is the cystic fibrosis therapeutics market?

The global cystic fibrosis therapeutics market size reached US$ 6.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 11.2 Billion by 2028, exhibiting a growth rate (CAGR) of 9% during 2023-2028.

Cystic Fibrosis Therapeutics Market Report 2023-2028

Cystic Fibrosis Therapeutics Market Outlook:

Cystic fibrosis refers to an inherited disease in which the lungs and digestive system become clogged with sticky, thick mucus. This condition modifies the electrolyte transport system, triggering cells to absorb sodium and water, thus leading to difficulties linked to glands that create mucous and sweat. If left untreated, lungs become highly damaged and may eventually cease to function. The management and treatment of cystic fibrosis include physical therapy, gene therapy, physiotherapy and nutritional support. Along with this, medicinal drugs, such as pancreatic enzyme supplements, mucolytics, bronchodilators and cystic fibrosis transmembrane conductance regulator (CFTR) modulators are also used for targeting cellular interactomes and symptomatic improvement.

Request a Free PDF Sample of the Report: https://www.imarcgroup.com/cystic-fibrosis-therapeutics-market/requestsample

Cystic Fibrosis Therapeutics Market Trends and Growth Drivers:

The rising number of individuals suffering from cystic fibrosis represents one of the key factors driving the market growth. Moreover, the widespread adoption of CFTR modulators as a treatment alternative is contributing to the market. In addition to this, various technological advancements, such as the development of personalized drug therapy, molecular prosthetics, and innovative drugs with improved efficacy, are acting as another growth-inducing factor. Other factors, including rising healthcare expenditures, increasing health consciousness, and awareness regarding the available treatment options for cystic fibrosis, are expected to create a positive outlook of the market. 

Cystic Fibrosis Therapeutics Market 2023-2028 Competitive Analysis and Segmentation:

Competitive Landscape with Key Players:                          

The competitive landscape of the global cystic fibrosis therapeutics market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

• AbbVie Inc.
• Alaxia
• Alcresta Therapeutics Inc.
• Allergan
• AstraZeneca
• Hoffmann-La Roche Ltd.
• Gilead Sciences Inc.
• Merck & Co. Inc.
• Novartis AG
• Teva Pharmaceutical Industries Ltd.
• Vertex Pharmaceuticals Inc.

Key Market Segmentation:

The report has segmented the global cystic fibrosis therapeutics market on the basis of drug class, drug molecule type, route of administration, end-user and region.

Breakup by Drug Class:

• Pancreatic Enzyme Supplements
• Mucolytics
• Bronchodilators
• CFTR Modulators
• Antibiotics
• Others

Breakup by Drug Molecule Type:

• Small Molecule Drugs
• Biologics

Breakup by Route of Administration:

• Oral Drugs
• Inhaled Drugs

Breakup by End-User:

• Hospitals
• Clinics
• Others

Breakup by Region:

• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa

Speak to Analyst: https://www.imarcgroup.com/request?type=report&id=2117&flag=C

Note: This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form.

Key Highlights of the Report:

• Market Performance (2017-2022)
• Market Insight (2023-2028)
• Market Trends
• Market Growth Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:                      

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Media Contact:
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: sales@imarcgroup.com
Phone: +1-631-791-1145
Address: 134 N 4th St
City: Brooklyn
State: NY
Country: United States
Website: https://www.imarcgroup.com